NGS Serves to Promote ‎Personalized Medicine: A Case-‎Report of a Patient with Invasive ‎Breast Carcinoma

The emergence of personalized medicine based on molecular techniques, such as next-generation sequencing, has increased our understanding of drivers of complex diseases, including cancers. In many cases due to the complexity of cancer, it is difficult for human physicians and biologists to make decisions on the basis solely of clinical practice or laboratory evidence. Thus, the personalized medicine approach comes into play and provides large volumes and valuable data for experts. Further, data analysis with bioinformatic tools has opened a new horizon in the process of prognosis and screening of in risk individuals. It has caused significant recent advances in diagnostic technology and improved targeted treatments. In the present study, archived formalin-fixed paraffin-embedded tissue from an Iranian female patient with invasive breast carcinoma was investigated. In this way, after DNA extraction and purification, the whole exome was sequenced and the mutation data were analyzed. Obtained information could help to the enrichment of the Iranian genome databases. In the light of this research and by studying other Iranian samples, we can provide an optimized roadmap for precision oncologists to increase the life expectancy of breast cancer patients.